Evidence map›Paper›PMID 40530719›Full record

ReviewMicroRNA (Shariqah, United Arab Emirates)2026

Equine MicroRNAs: Performance, Reproduction, and Disease.

Marcos Edgar Herkenhoff

Abstract readReview
PubMed Publisher
In one paragraph

Review in MicroRNA (Shariqah, United Arab Emirates), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Marcos Edgar HerkenhoffDepartment of Biochemical and Pharmaceutical Technology, School of Pharmaceutical Sciences, University of São Paulo (USP). Av. Professor Lineu Prestes, 580, São Paulo, SP, 05508-000, Brazil.ORCID 0000-0001-9298-6177

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

MicroRNAs (miRNAs) are molecules that regulate gene expression by targeting the 3' untranslated region (UTR) of mRNAs. They are essential in numerous biological processes like growth, metabolism, and muscle development. miRNA research has become crucial in livestock breeding, offering solutions for improving animal health and productivity. This review focuses on miRNAs' roles in equine performance, reproduction, and disease, highlighting key findings and future applications in these areas. It discusses the use of circulating miRNAs (ci-miRNA) as biomarkers for athletic performance, particularly in endurance sports, by monitoring responses to exercise-induced stress and recovery. It also examines miRNAs involved in reproductive health, such as those influencing endometritis, oocyte maturation, and embryo development. In terms of disease, miRNAs are highlighted as potential biomarkers for osteoarthritis and sarcoids, offering insights into early diagnosis and treatment. Overall, the review emphasizes the promise of miRNAs in improving equine care through personalized diagnostics and therapeutic approaches.

Indexed as

Horse DiseasesMicroRNAsReproductionAnimalsBiomarkersFemaleGene Expression RegulationHorsesBiomarkersMicroRNAsdiseasesfarm animalsgene expressionHorsemicroRNAsperformancereproduction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.